» Authors » Kenneth A Jamerson

Kenneth A Jamerson

Explore the profile of Kenneth A Jamerson including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 48
Citations 7573
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Brook R, Kaciroti N, Bakris G, Dahlof B, Pitt B, Velazquez E, et al.
J Am Heart Assoc . 2018 Jan; 7(1). PMID: 29301757
Background: The ACCOMPLISH (Avoiding Cardiovascular Events Through Combination Therapy in Patients Living with Systolic Hypertension) trial demonstrated that combination therapy using amlodipine, rather than hydrochlorothiazide, in conjunction with benazepril provided...
12.
13.
14.
15.
16.
Egan B, Bland V, Brown A, Ferdinand K, Hernandez G, Jamerson K, et al.
J Clin Hypertens (Greenwich) . 2015 Mar; 17(4):252-9. PMID: 25756743
A 2014 hypertension guideline raised goal systolic blood pressure (SBP) from <140 mm Hg to <150 mm Hg for adults 60 years and older without diabetes mellitus (DM) or chronic...
17.
Skoglund P, Svensson P, Asp J, Dahlof B, Kjeldsen S, Jamerson K, et al.
J Clin Hypertens (Greenwich) . 2014 Dec; 17(2):141-6. PMID: 25529596
Pulse pressure (PP) is an independent risk factor for cardiovascular (CV) disease and death but few studies have investigated the effect of antihypertensive treatments in relation to PP levels before...
18.
19.
Gabbai F, Rahman M, Hu B, Appel L, Charleston J, Contreras G, et al.
Clin J Am Soc Nephrol . 2012 Sep; 7(11):1770-6. PMID: 22935847
Background And Objectives: Abnormal ambulatory BP (ABP) profiles are commonplace in CKD, yet the prognostic value of ABP for renal and cardiovascular outcomes is uncertain. This study assessed the relationship...
20.
Weir M, Bakris G, Weber M, Dahlof B, Devereux R, Kjeldsen S, et al.
Kidney Int . 2011 Dec; 81(6):568-76. PMID: 22189843
The ACCOMPLISH trial (Avoiding Cardiovascular events through Combination therapy in Patients Living with Systolic Hypertension) was a 3-year multicenter, event-driven trial involving patients with high cardiovascular risk who were randomized...